Literature DB >> 6751336

Serum pepsinogen I in rheumatic diseases. Reduced levels in Sjögren's syndrome.

C P Maury, V Räsänen, A M Teppo, T Helve, O Wegelius.   

Abstract

Group I pepsinogens were measured by radioimmunoassay in the sera of 93 patients with rheumatic diseases and 99 controls. Patients with rheumatoid arthritis and systemic lupus erythematosus had levels of pepsinogen I similar to controls, whereas patients with Sjögren's syndrome had levels significantly lower than either controls (P less than 0.001) or patients with rheumatic diseases not associated with sicca syndrome (P less than 0.001). The concentrations of serum pepsinogen I were lower in patients with sicca syndrome alone than in those with sicca syndrome associated with some other connective tissue disease (P less than 0.05). In patients with Sjögren's syndrome, a negative correlation was found between serum concentrations of beta 2-microglobulin and pepsinogen I (r = -0.46, P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751336     DOI: 10.1002/art.1780250905

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

1.  Antibodies to gliadin, gluten and reticulin glycoprotein in rheumatic diseases: elevated levels in Sjögren's syndrome.

Authors:  A M Teppo; C P Maury
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

2.  Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus.

Authors:  C P Maury; T Helve; C Sjöblom
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

3.  Types of atrophic gastritis in patients with primary Sjögren's syndrome.

Authors:  G Pokorny; G Karácsony; J Lonovics; J Hudák; J Németh; V Varró
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.